loadpatents
name:-0.014159202575684
name:-0.0016529560089111
name:-0.00045323371887207
McIntosh; Christopher H.S. Patent Filings

McIntosh; Christopher H.S.

Patent Applications and Registrations

Patent applications and USPTO patent grants for McIntosh; Christopher H.S..The latest application filed is for "use of dipeptidyl peptidase iv effectors for normalizing the blood glucose level in mammals".

Company Profile
0.1.11
  • McIntosh; Christopher H.S. - Vancouver CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Use of Dipeptidyl Peptidase IV Effectors for Normalizing the Blood Glucose Level in Mammals
App 20170007582 - Demuth; Hans-Ulrich ;   et al.
2017-01-12
Use of Dipeptidyl Peptidase IV Effectors for Normalizing the Blood Glucose Level in Mammals
App 20130116290 - Demuth; Hans-Ulrich ;   et al.
2013-05-09
Dipeptidyl peptidase IV inhibitors and their uses for lowering blood pressure levels
App 20070207946 - Pospisilik; Andrew J. ;   et al.
2007-09-06
Novel analogues of glucose-dependent insulinotropic polypeptide
App 20050137135 - Hinke, Simon A. ;   et al.
2005-06-23
Use of dipeptidyl peptidase IV effectors for normalizing the blood glucose level in mammals
App 20050107309 - Demuth, Hans-Ulrich ;   et al.
2005-05-19
Dipeptidyl peptidase IV inhibitors and their uses for lowering blood pressure levels
App 20050107308 - Pospisilik, Andrew J. ;   et al.
2005-05-19
Novel analogues of glucose-dependent insulinotropic polypeptide
App 20030232761 - Hinke, Simon A. ;   et al.
2003-12-18
Dipeptidyl peptidase IV inhibitors and their uses for lowering blood pressure levels
App 20030176357 - Pospisilik, Andrew J. ;   et al.
2003-09-18
Use of dipeptidyl peptidase IV effectors for normalizing the blood glucose level in mammals
App 20020110560 - Demuth, Hans-Ulrich ;   et al.
2002-08-15
Use of dipeptidyl peptidase IV effectors for lowering blood pressure in mammals
App 20020006899 - Pospisilik, Andrew J. ;   et al.
2002-01-17
Use of dipeptidyl peptidase IV effectors for lowering the blood glucose level in mammals
Grant 6,303,661 - Demuth , et al. October 16, 2
2001-10-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed